Blackstone Considers $2 Billion Exit for ZO Skin Health
Blackstone is exploring an exit for ZO Skin Health, a skincare brand sold mainly through physicians and skincare professionals. Growing buyer interest in clinically focused, doctor-recommended products could support a sale near $2 billion, allowing Blackstone to monetize its investment and potentially reinvest or return proceeds, as buyers remain selective.